Lugano, Switzerland – Singapore, 22 December, 2021 – Helsinn Healthcare SA (“Helsinn”), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and Juniper Biologics Pte Ltd (“Juniper”), a science-led healthcare company focused on researching, developing and commercializing novel therapies, announced today the signing of exclusive […]